CD19 CAR T cell treatment also has a significant anti-tumor effect in follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and multiple myeloma (MM) [68,69]. Here, CD19 is linked to plasma cell myeloma.